Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Randal D. Chase currently holds 6,000 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Randal D. Chase has been a net buyer of BJCT stock. They have purchased $147.0K and sold $0 worth of shares.
Randal D. Chase's most recent insider trade was on Jun 17, 2026, when they sold 6,000 shares at $0.00 per share.
Randal D. Chase serves as Executive at BIOJECT MEDICAL TECHNOLOGIES INC (BJCT). They have executed 18 insider transactions totaling $147.0K over their tenure at the company.
Randal D. Chase holds the position of Executive at BIOJECT MEDICAL TECHNOLOGIES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Randal D. Chase has shown a buying trading pattern, with $147.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Randal D. Chase was on Sep 29, 2020, when they purchased $83.1K worth of GOVX shares. This transaction involved 16,613 shares at $5.00 per share.
Randal D. Chase currently owns 6,000 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Randal D. Chase's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Randal D. Chase has 18 Form 4 filings on record as an insider at BIOJECT MEDICAL TECHNOLOGIES INC.
Set alerts for Randal D. Chase and 40,000+ other insiders.